Sign in
Join
Home
About Us
Privacy Policy
Disclaimer
Advertise On Market Exclusive
About Marketexclusive.com Contributors
Sitemap
Submit a Scoop!
Contact Us
Become a Contributor!
Stock Market News
Stocks
Analyst Ratings
Insider Trading
SEC Filings
Earnings
Biotech Stocks
Small Caps
Blockchain & Cryptocurrency
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
My Account
orders
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Market Exclusive
Home
About Us
Privacy Policy
Disclaimer
Advertise On Market Exclusive
About Marketexclusive.com Contributors
Sitemap
Submit a Scoop!
Contact Us
Become a Contributor!
Stock Market News
Stocks
Analyst Ratings
Insider Trading
SEC Filings
Earnings
Biotech Stocks
Small Caps
Blockchain & Cryptocurrency
Home
Featured
Featured
Featured posts
Random
Latest
Featured posts
Most popular
7 days popular
By review score
Random
AveXis Inc (NASDAQ:AVXS): Of Course The FDA Didn’t Ask For Placebo Data
ME Contributor
-
November 3, 2016
Why the Performance of Sarepta Therapeutics Inc. (NASDAQ:SRPT) Eteplirsen Could Determine the Future of Drug Regulation
Highlighting ZIOPHARM Oncology Inc. (NASDAQ:ZIOP) As A Catalyst Play This Quarter
Off the Radar Dermira Targets a Billion Dollar Opportunity
Here’s Why Capricor Therapeutics Inc (NASDAQ:CAPR) Is Running This Week
Trial Data Is Driving Gains In Kura Oncology, Inc. And (NASDAQ:KURA)...
ME Contributor
-
September 8, 2017
0
The Ups And Downs Of Novartis AG (ADR) (NYSE:NVS)’s Latest Approval
ME Contributor
-
May 30, 2017
0
Here’s A Near Term Opportunity In Oncology
ME Staff
-
October 16, 2015
0
Two Big Parkinson’s Updates From Adamas Pharmaceuticals Inc (NASDAQ:ADMS) And Acorda...
ME Contributor
-
August 5, 2016
0
Biotech Movers: Stemline Therapeutics, Inc. (NASDAQ:STML) And Mylan N.V. (NASDAQ:MYL)
ME Contributor
-
November 1, 2017
0
Two Biotechs With Bad News This Week: What Happens Now?
ME Contributor
-
September 15, 2016
0
Why Corbus Pharmaceuticals Holdings Inc (NASDAQ:CRBP) Climbed 23% This Week
Rafi Farber
-
August 19, 2016
0
Ebola Silver Bullet a Social Not Financial Win for Merck
Jennifer Aldershot
-
August 5, 2015
0
How NeuroRx Pharma is Turning Suicidal Ideation Into A Treatable Condition
David Rich
-
November 30, 2016
0
Biotech 101: Knowing Your Designations
Jennifer Aldershot
-
September 23, 2015
0
1
2
3
...
80
Page 1 of 80